Truist Financial
CSTL icon

Truist Financial’s Castle Biosciences CSTL Stock Holding History

Truist Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
23,786
+5
+0% +$111 ﹤0.01% 2126
2026
Q1 		$584K Buy
23,781
+153
+0.6% +$5.01K ﹤0.01% 1992
2025
Q4 		$919K Buy
23,628
+257
+1% +$8.29K ﹤0.01% 1702
2025
Q3 		$532K Sell
23,371
-652
-3% -$13.2K ﹤0.01% 1994
2025
Q2 		$491K Buy
24,023
+1,715
+8% +$31.8K ﹤0.01% 1978
2025
Q1 		$447K Buy
22,308
+1,005
+5% +$24.9K ﹤0.01% 1932
2024
Q4 		$568K Buy
21,303
+928
+5% +$28.3K ﹤0.01% 1799
2024
Q3 		$581K Buy
20,375
+6,158
+43% +$157K ﹤0.01% 1786
2024
Q2 		$310K Buy
14,217
+2,420
+21% +$53.9K ﹤0.01% 2278
2024
Q1 		$261K Buy
11,797
+167
+1% +$3.63K ﹤0.01% 2356
2023
Q4 		$251K Sell
11,630
-1,467
-11% -$25.8K ﹤0.01% 2409
2023
Q3 		$221K Buy
13,097
+198
+2% +$3.46K ﹤0.01% 2410
2023
Q2 		$177K Buy
+12,899
New +$261K ﹤0.01% 2458
2022
Q2 		– Sell
-6,510
Closed -$292K – 2653
2022
Q1 		$292K Buy
6,510
+379
+6% +$15.7K ﹤0.01% 2337
2021
Q4 		$262K Sell
6,131
-237
-4% -$12.4K ﹤0.01% 2450
2021
Q3 		$424K Sell
6,368
-171
-3% -$12K ﹤0.01% 2104
2021
Q2 		$480K Buy
+6,539
New +$432K ﹤0.01% 2086

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Truist Financial's CSTL Position: Q2 2026 in Review

Truist Financial increased its Castle Biosciences (CSTL) stake by 0.02% in Q2 2026, buying an estimated $111 and bringing the position to 23,786 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #2126.

Truist Financial first reported a position in CSTL in Q2 2021 and has held it in 17 quarters since. The position peaked at $919K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Truist Financial held 23,786 shares of Castle Biosciences worth $567K as of Q2 2026.
  • Truist Financial bought 5 Castle Biosciences shares in Q2 2026, an estimated $111.
  • Castle Biosciences made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2126 holding.
  • Truist Financial first reported a position in Castle Biosciences in Q2 2021 and has held it in 17 quarters since.
  • Truist Financial's Castle Biosciences position peaked at $919K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.